DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...

Medtronic plcMDT announced the receipt of FDA approval for the Guardian Connect continuous glucose monitoring (CGM) system for diabetes patients between the ages of 14 to 75 years. Notably, the system ...

Medtronic plc MDT recently released real-world data on its Guardian Connect continuous glucose monitoring (CGM) system and Sugar.IQ diabetes assistant app. The data was presented at the 79 th ...

Medtronic plc MDT recently announced the receipt of the FDA’s approval for the Android version of its Guardian Connect continuous glucose monitoring (CGM) system. The Guardian Connect CGM system, a ...

Medtronic’s Guardian Connect continuous glucose monitoring system earned FDA approval March 12. Here are four things to know. 1. The Guardian Connect system uses predictive analytics and artificial ...

Medtronic plc. MDT recently made a major development in the field of diabetes management. The company reached an outcome-based agreement with Blue Cross and Blue Shield of Minnesota in relation to the ...

Back in the day – roughly around 2007, Medtronic offered a standalone continuous glucose monitoring system where diabetics who were not using a Medtronic insulin pump could use it to get continuous ...

Users also have access to the Company's Sugar.IQ app, which uses IBM's Watson Health platform, to identify glucose patterns based on factors that may affect them (ie, food intake, insulin dosages, ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved the first smart continuous glucose monitoring system designed to alert patients with ...

On Friday, a diabetes expert described Medtronic’s Sugar.IQ diabetes assistant as a “key differentiator” among all the continuous glucose monitoring systems available in the market. Roy Beck, an ...